CPCLIN - Centro de Pesquisas Clínicas /ID# 161818
São Paulo 01244-030
0 studies enrolling now · 1 studies all time
What they study most
Psoriatic Arthritis
Studies at this site
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
— Completed